OMB control number

[NCHHSTP] CDC Model Performance Evaluation Program (MPEP) for Mycobacterium tuberculosis Drug Susceptibility Testing

OMB 0920-0600 ยท HHS/CDC.

OMB 0920-0600

The goal of the study is to collect and analyze the performance and practices of clinical and public health laboratories in the United States that perform drug susceptibility testing of isolates belonging to the Mycobacterium tuberculosis complex (MTBC), a genetically related group of Mycobacterium species that can cause tuberculosis in humans. The TB Model Performance Evaluation Program (MPEP) assesses the ability of laboratories to test for drug resistant MTBC strains, providing laboratories a self-assessment tool to aid in optimizing their skills in susceptibility testing. This Revision has a few minor edits.

The latest form for [NCHHSTP] CDC Model Performance Evaluation Program (MPEP) for Mycobacterium tuberculosis Drug Susceptibility Testing expires 2028-12-31 and is listed under ICR 202511-0920-002.

Latest Forms, Documents, and Supporting Material

Latest forms, documents, and information collections
DocumentType
Participant Biosafety Compliance AgreementForm and Instruction
Participant Biosafety Compliance Letter of AgreementForm and Instruction
Results WorksheetForm and Instruction
MPEP Mycobacterium Tuberculosis ResultsForm and Instruction
MIC Results FormForm and Instruction
Minimum Inhibitory Concentration ReportsForm and Instruction
Online Survey Instrument WebshotsForm and Instruction
Online Survey InstrumentForm and Instruction
SSB.docxSupporting Statement B
SSB.docxSupporting Statement B
SSA_8.27.2025_final.docxSupporting Statement A
SSA_8.27.2025_final.docxSupporting Statement A
Att. 14-PIA Form.pdfSupplementary Document
Att. 14-PIA Form.pdf Supplementary Document
Att. 13-Final Report.pdfSupplementary Document
Att. 13-Final Report.pdf Supplementary Document
Att. 12-Final Report Letter.docxSupplementary Document
Att. 11-Expected Results Report.pdfSupplementary Document
Att. 11-Expected Results Report.pdf Supplementary Document
Att. 10-Reminder Email.docxSupplementary Document
Att. 10-Reminder Email.docx Supplementary Document
Att. 7-Instructions for Participants.docxSupplementary Document
Att. 6-Preshipment Email.docxSupplementary Document
Att. 6-Preshipment Email.docx Supplementary Document
Att. 3-Explanation of changes.docxSupplementary Document
Att. 3-Explanation of changes.docx Supplementary Document
Att. 2-60 Day FRN Published.pdfSupplementary Document
Att. 2-60 Day FRN Published.pdf Supplementary Document
Att. 1-Authorizing Legislation.docxSupplementary Document
Att. 1-Authorizing Legislation.docx Supplementary Document
Participant Biosafety Compliance Letter of Agreement Form and Instruction
Participant Biosafety Compliance Letter of Agreement Form and Instruction
MPEP Mycobacterium Tuberculosis Results Form and Instruction
MPEP Mycobacterium Tuberculosis Results Form and Instruction
Minimum Inhibitory Concentration Reports Form and Instruction
Minimum Inhibitory Concentration Reports Form and Instruction
Online Survey Instrument Form and Instruction
Online Survey Instrument Form and Instruction

OMB Details

Participant Biosafety Compliance Letter of Agreement

Federal Enterprise Architecture: Health - Public Health Monitoring

Information collection instruments
FormNameElectronic accessType
Form n/aParticipant Biosafety Compliance AgreementFillable FileableForm and instruction

Review document collections for all forms, instructions, and supporting documents - including paper/printable forms.